TSU-68 (SU6668, Orantinib) has greatest potency against PDGFR autophosphorylation with Ki of 8 nM, but also strongly inhibits Flk-1 and FGFR1 trans-phosphorylation, little activity against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2; does not inhibit EGFR.
仅供研究使用。 我们不向患者出售。
名称 | TSU-68(SU6668,Orantinib) |
---|---|
Iupac 化学名称 | (Z)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid |
同义词 | TSU-68,SU6668,Orantinib |
英文同义词 | TSU-68,SU6668,Orantinib |
分子式 | C18H18N2O3 |
分子量 | 310.35 |
Smile | CC=1NC(=C(C1CCC(=O)O)C)\C=C\1/C(NC2=CC=CC=C12)=O |
InChiKey | NHFDRBXTEDBWCZ-ZROIWOOFSA-N |
InChi | InChI=1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9- |
Cas号 | 252916-29-3 |
相关CAS号 |
包装 | 价格 | 库存 | 纯度 | 备货期 |
---|---|---|---|---|
大货 | 询价 | 询价 | 询价 |